# Johnson & Johnson (JNJ) total liabilities history

URL: https://funkfolio.com/stock/JNJ/total-liabilities

> Johnson & Johnson (JNJ) total liabilities were $117.67B at the end of fiscal 2025, up 8.3% from fiscal 2024. Year-by-year chart and table.

---

## Johnson & Johnson (JNJ) total liabilities

**Total liabilities · fiscal 2025:** $117.67B at Dec 31, 2025

Johnson & Johnson (JNJ) had total liabilities of $117.67B at the end of fiscal 2025 (December 31, 2025). That is 8.3% higher than the $108.61B of fiscal 2024. Figures as of 18 Nov 2026, 21:06 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Total liabilities, fiscal 2025:** $117.67B
- **Change on fiscal 2024:** +8.3%
- **Highest on record:** $117.67B fiscal 2025
- **Lowest on record:** $42.40B fiscal 2008
- **Fiscal years on record:** 18 2008–2025

Figures as of 18 Nov 2026, 21:06 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Johnson & Johnson total liabilities, in more detail

Across the 18 fiscal years on record (2008–2025), the highest was $117.67B in fiscal 2025 and the lowest $42.40B in fiscal 2008.

### Total liabilities by fiscal year

### Johnson & Johnson total liabilities, year by year

Johnson & Johnson (JNJ) total liabilities by fiscal year

| Fiscal year | Total liabilities | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $117.67B | 8.3% up | Dec 31, 2025 |
| 2024 | $108.61B | 10.0% up | Dec 31, 2024 |
| 2023 | $98.78B | 10.7% down | Dec 31, 2023 |
| 2022 | $110.57B | — | Dec 31, 2022 |
| 2022 | $108.00B | 3.2% down | Jan 2, 2022 |
| 2021 | $111.62B | — | Jan 3, 2021 |
| 2019 | $98.26B | 5.4% up | Dec 29, 2019 |
| 2018 | $93.20B | 4.1% down | Dec 30, 2018 |
| 2017 | $97.14B | — | Dec 31, 2017 |
| 2017 | $70.79B | 13.7% up | Jan 1, 2017 |
| 2016 | $62.26B | — | Jan 3, 2016 |
| 2014 | $60.61B | 3.4% up | Dec 28, 2014 |
| 2013 | $58.63B | 3.7% up | Dec 29, 2013 |
| 2012 | $56.52B | — | Dec 30, 2012 |
| 2012 | $56.56B | 22.1% up | Jan 1, 2012 |
| 2011 | $46.33B | 5.1% up | Jan 2, 2011 |
| 2010 | $44.09B | — | Jan 3, 2010 |
| 2008 | $42.40B | — | Dec 28, 2008 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

### How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

### Total liabilities at health care companies of similar size

Total liabilities of Johnson & Johnson and comparable companies

| Company | Total liabilities | Fiscal year |
| --- | --- | --- |
| [Eli Lilly LLY](https://funkfolio.com/stock/LLY/total-liabilities) | $85.94B | 2025 |
| Johnson & Johnson JNJ | $117.67B | 2025 |
| [AbbVie ABBV](https://funkfolio.com/stock/ABBV/total-liabilities) | $137.19B | 2025 |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/total-liabilities) | $84.20B | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/total-liabilities) | $207.88B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/total-liabilities) | $64.40B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Johnson & Johnson, figure by figure

- [Johnson & Johnson market cap](https://funkfolio.com/stock/JNJ/market-cap)
- [Johnson & Johnson revenue](https://funkfolio.com/stock/JNJ/revenue)
- [Johnson & Johnson earnings](https://funkfolio.com/stock/JNJ/earnings)
- [Johnson & Johnson earnings per share (EPS)](https://funkfolio.com/stock/JNJ/eps)
- [Johnson & Johnson P/E ratio](https://funkfolio.com/stock/JNJ/pe-ratio)
- [Johnson & Johnson P/S ratio](https://funkfolio.com/stock/JNJ/ps-ratio)
- [Johnson & Johnson P/B ratio](https://funkfolio.com/stock/JNJ/pb-ratio)
- [Johnson & Johnson free cash flow](https://funkfolio.com/stock/JNJ/free-cash-flow)
- [Johnson & Johnson operating margin](https://funkfolio.com/stock/JNJ/operating-margin)
- [Johnson & Johnson dividend](https://funkfolio.com/stock/JNJ/dividend)
- [Johnson & Johnson shares outstanding](https://funkfolio.com/stock/JNJ/shares-outstanding)
- [Johnson & Johnson total debt](https://funkfolio.com/stock/JNJ/total-debt)
- [Johnson & Johnson cash on hand](https://funkfolio.com/stock/JNJ/cash)
- [Johnson & Johnson total assets](https://funkfolio.com/stock/JNJ/total-assets)
- [Johnson & Johnson net assets (shareholders' equity)](https://funkfolio.com/stock/JNJ/net-assets)
- [Johnson & Johnson return on equity (ROE)](https://funkfolio.com/stock/JNJ/roe)
- [Johnson & Johnson return on invested capital (ROIC)](https://funkfolio.com/stock/JNJ/roic)

[Johnson & Johnson (JNJ) overview: price, valuation and scorecard](https://funkfolio.com/stock/JNJ) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Johnson & Johnson total liabilities: questions and answers

**How large are Johnson & Johnson's total liabilities?**

Johnson & Johnson (JNJ) had total liabilities of $117.67B at the end of fiscal 2025 (December 31, 2025). That is 8.3% higher than the $108.61B of fiscal 2024.

**What are the highest and lowest total liabilities figures on record for Johnson & Johnson?**

Across the 18 fiscal years on record (2008–2025), the highest was $117.67B in fiscal 2025 and the lowest $42.40B in fiscal 2008.

**How is Johnson & Johnson's total liabilities calculated?**

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Johnson & Johnson it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: total liabilities

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Johnson & Johnson (JNJ) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/JNJ/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.
